Overview

A Study of OMX-0407 in Patients With Previously Treated Solid Tumours That Can't be Removed Surgically

Status:
Recruiting
Trial end date:
2025-05-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to determine the safety of different doses of OMX-0407. The study will also evaluate how the drug is distributed and exits the human body.
Phase:
Phase 1
Details
Lead Sponsor:
iOmx Therapeutics AG